Get notified when SLXN files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — Auditor opinion includes going concern explanatory paragraph; management disclosed substantial doubt about ability to continue as going concern due to cash runway of only several months as of March 31, 2026.
- Nasdaq Equity Deficiency (new) — Shareholders' equity fell below Nasdaq's $2.5M minimum requirement after being compliant at $2.6M as of March 31, 2026; company is dependent on this offering to regain compliance, with no assurance of success.
- Mandatory Monitoring Period (new) — Company is under Nasdaq panel monitoring through September 23, 2026; any new equity deficiency during this period triggers immediate delisting proceedings without the usual cure period.
- Reverse Split Delisting Trigger (new) — If share price closes below $1.00 for 30 consecutive days before May 29, 2027 (one year after May 2026 reverse split), company faces immediate delisting proceedings.
Silexion prices $5M offering at $1.87/share, nearly tripling share count amid Nasdaq equity gap
Filed August 10, 2026 · Compared to S-1 Aug 7, 2026 · ~2 min read
Key Changes
-
high
Offering of up to 2.67M shares at $1.87 would increase outstanding shares 198% (from 1.35M to 4.02M), with net proceeds of $4.3M extending cash runway into Q1 2027 at best; without the raise, existing cash covers only several months.
Use of Proceeds / Dilution view on EDGAR → -
high
Shareholders' equity currently below Nasdaq's $2.5M minimum; company is under mandatory monitoring through Sept 2026 with no cure period for repeat deficiencies, and faces immediate delisting if share price closes below $1.00 for 30 days before May 2027.
Risk Factors: Nasdaq Compliance verify on EDGAR → -
high
Auditor opinion includes going concern explanatory paragraph; management concluded substantial doubt exists about ability to continue as going concern due to cash runway of only several months as of March 31, 2026.
MD&A / Experts view on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FPS 10-K) is open in full — no account needed.
Partner
Trade SLXN commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 16, 2026 · How we verify